Inmed pharmaceuticals to report third quarter fiscal 2021 financial results

Vancouver, british columbia, may 06, 2021 (globe newswire) -- inmed pharmaceuticals inc. (“inmed” or the “company”) (nasdaq:inm; tsx:in), a clinical-stage company developing pharmaceutical-based drug candidates and leading the way in the clinical development of cannabinol (“cbn”), will report financial results on thursday, may 13, 2021 for the third quarter of fiscal year 2021 ending march 31, 2021.
INM Ratings Summary
INM Quant Ranking